期刊文献+

胃酸调节肽C端8肽对胰腺炎大鼠胰腺外分泌的影响 被引量:2

Influence of oxyntomodulin C-terminal octapeptide on exocrine function in experimental pancreatitis rats
原文传递
导出
摘要 目的探讨胃酸调节肽C端8肽(KA-8肽)对蛙皮素诱导的急性水肿性胰腺炎胰腺外分泌影响。方法采用Wistar大鼠蛙皮素皮下注射诱导急性水肿性胰腺炎,收集胰液计量,并检测蛋白和碳酸氢盐的含量;胰腺干湿比、Evans blue漏出率、胰腺组织蛋白/DNA评价胰腺水肿情况。结果KA-8肽和生长抑素对蛙皮素所致的胰腺外分泌功能的升高有明显的抑制作用(59.7±19.5比89.8±18.9;37.5±7.8比89.8±18.9,单位:μl/30min),但并不能影响胰液中蛋白的含量(0.50±0.16比0.47±0.19;0.53±0.19比0.47±0.19,单位:mg/30min);两种多肽可明显降低胰腺组织水肿(干湿比:0.20±0.08比0.15±0.08;0.19±0.09比0.15±0.08)。结论KA-8肽对蛙皮素诱导的急性水肿性胰腺炎有一定的保护作用。 Objective To study the influence of oxyntomodulin C-terminal octapeptide (KA-8 peptide) on the exocrine function in cearulein-induced acute pancreatitis. Methods Acute pancreatitis of Wistar rats was induced by cearulein, The inflammation was evaluated by histology. Protein and bicarbonate concentrations in pancreatic fluid were determined. The enema was evaluated by ratio of dry/wet, extravasation of Evans blue dye, ratio of pancreas protein/DNA. Results Acute edematous pancreatitis could be induced by cearulein. KA-8 peptide and somatostatin could inhibit the enhanced secretion of pancreas after AP (59.7 ± 19.5 vs 89.8 ± 18,9; 37.5 ± 7.8 vs 89.8 ± 18.9 μL/30 min, respectively), but had no influence on the protein in pancreatic fluid (0.50 ± 0.16 vs 0.47 ± 0.19 ; 0, 53 ± 0.19 vs 0.47 ± 0.19 mg/30 min respectively). At the same time, the two agents could decrease the enema of pancreas (ratio of dry/wet: 0.20 ± 0.08 vs 0.15 ± 0.08 ;0.19 ± 0.09 vs 0.15 ± 0.08 respectively), Conclusion KA-8 peptide can protect the pancreas to varying degrees in cearulein-induced acute pancreatitis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第1期41-42,共2页 Chinese Journal of Experimental Surgery
基金 北京市卫生重点学科项目(1998卫科扶字11号)
关键词 胃酸调节肽C端8肽 胰腺炎 大鼠 动物实验 胰腺外分泌 蛙皮素 Acute pancreatitis peptide Cearulein
  • 相关文献

参考文献3

二级参考文献16

共引文献69

同被引文献25

  • 1王霄虹,左谦,寿吉平,艾厚喜,姬志娟,刘大川,盛树力.胃酸分泌调节肽和KA8肽的生物活性研究[J].首都医学院学报,1994,15(1):34-37. 被引量:1
  • 2Bataille D, Tatemoto K, Gespach C, et al. Isolation of glucagon-37(bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide[J]. FEBS Lett, 1973, 146, 79-86.
  • 3Bonnet C, Martinez, C, Jarrousse A, et al. H-Lys-Arg-Asn- Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin[J]. Elsevier Science Inc,1995, 17(3): 557-561.
  • 4Bell G I,Sanchez-Pescador R, Laybourn P J, et al. Exon duplication and divergence in the human preproglucagon gene[J]. Nature, 1983, 304, 368-371.
  • 5Lopez L C, Frazicr M L, Su C J, et al. Mammalian preproglucagon contains three glucagon related peptides[J]. Proc Natl Acad Sci USA, 1983, 80 :5485-5489.
  • 6Audousset-Puech M P, Dufour M, Kervran A, et al. Solidphase peptide synthesis of human (Nle-27)-oxyntomodulin. preliminary evaluation of its biological activities [J]. FEBS Lett,1986, 200:181-185.
  • 7Dakin C L, Small C J, Park A J, et al. Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rata[J]. Am J Physiol Endocrinol Metab,2002, 283, 1173-1177.
  • 8Cohen M A, Ellis S M, Le Roux C W, et al. Oxyntomodulin suppresses appetite and reduces food intake in humans[J]. J Clin Endocrinol Metab, 2003, 88: 4696-4701.
  • 9Dakin C L,Small C J, Batterham R L, et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats[J].Endocrinology,2004, 145: 2687-2695.
  • 10Wynne K,Park A J, Small C J, et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects, a double blind, randomized, controlled trial[J]. Diabetes,2005, 54(8): 2390-2395.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部